Drug Report History #279969
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v3-EN | Version v1-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2026-03-17 (Updated) | 2026-03-09 |
| Drug Identification Number | 02503352 | 02503352 |
| Brand name | BORTEZOMIB FOR INJECTION SDZ | BORTEZOMIB FOR INJECTION SDZ |
| Common or Proper name | BORTEZOMIB FOR INJECTION | BORTEZOMIB FOR INJECTION |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | BORTEZOMIB | BORTEZOMIB |
| Strength(s) | 3.5MG | 3.5MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS | SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 1LYVI | 1LYVI |
| Anatomical Therapeutical Chemical (ATC) code | L01XG | L01XG |
| Anatomical Therapeutical Chemical (ATC) description | ||
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2026-03-09 | 2026-03-09 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |